EHC Stock Analysis: Buy, Sell, or Hold?
EHC - Encompass Health Corporation Common Stock
$102.25
2.35 (2.35%)
▲
5d:
+2.41%
30d:
-2.58%
90d:
+4.88%
BUY
MODERATE Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 03, 2026
Get Alerted When EHC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: EHC shows positive signals but monitor for confirmation. Market pricing in 2.1% decline. Moderate conviction.
💡 BUY OPPORTUNITY: EHC shows positive signals but monitor for confirmation. Market pricing in 2.1% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$148.79
Based on 6.4% avg growth
INTRINSIC VALUE TODAY
$92.39
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: EHC is currently trading at $102.25, which is considered fair relative to its 30-day fair value range of $100.03 to $105.08. The stock's valuation (Forward PE: 15.6) is in line with its historical norms (16.7). Remarkably, the market is currently pricing in an annual earnings decline of 2.1% over the next few years. This pessimistic expectation contrasts with the company's recent 30.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, EHC is showing sideways momentum. The price is currently testing key support at $99.78. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $140.50 (+37.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, EHC is showing sideways momentum. The price is currently testing key support at $99.78. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $140.50 (+37.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$100.03 -
$105.08
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 37.4% below Wall St target ($140.50)
Trading Range Analysis
30-Day Trading Range
$100.03 -
$105.08
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$99.78
Resistance Level
$106.92
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.64
Wall Street Target
$140.50
(+37.4%)
Revenue Growth (YoY)
9.0%
Earnings Growth (YoY)
30.3%
Profit Margin
10.0%
Valuation Discount vs History
-2.1% cheaper
PE vs Historical
15.6 vs 16.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.1%
(market-implied from PE analysis)
1-Year Target
$100.10
(-2%)
2-Year Target
$98.00
(-4%)
3-Year Target
$95.94
(-6%)
3-Yr Target (if PE normalizes)
(PE: 16→17)
$102.45
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 8.8%)
$183.45
(+79%)
Base:
(SPY PE: 15.6, Growth: 8.8%)
$131.73
(+29%)
Bear:
(PE: 13.3, Growth: 8.8%)
$111.97
(+10%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (17x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Trailing PE: 16.90 | Current EPS (TTM): $5.84
Bull Case
$121.52
(+22%)
Analyst growth 11.9%, PE expands to 18.6
Base Case
$110.47
(+11%)
Market implied 11.9%, PE stable at 16.9
Bear Case
$67.10
(-33%)
Severe decline -20.0%, PE contracts to 14.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 15.6 to 16.7
Stabilization Target:
$109.18
(+6.8%)
PE Expansion Potential:
+6.8%
Share & Embed Analysis
Last updated: June 24, 2026 5:52 PM ET
Data refreshes hourly during market hours. Next update: 6:52 PM
Data refreshes hourly during market hours. Next update: 6:52 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EHC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Edmund Fay
SELL
11937 shares
2026-03-09
Mark J Tarr
SELL
150000 shares
2026-02-11
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$244 | 57 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$504 | 58 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 54 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 58 HOLD |
|
OPCH
Option Care Health Inc |
STRONG BUY
10 analysts |
$29 | 61 BUY |
